Surely the site of mTOR activation is what we care about, right?
Doing a lifting session is going to temporarily stimulate mTOR in skeletal muscle as a means of recovery and adaptation. That’s how you undergo hypertrophy. I can’t think of any way in which that is detrimental to your health or longevity. More skeletal muscle means more strength, more glycogen stores, usually better metabolic health, less intramuscular fat and insulin resistance - all very very good things.
However, persistent/chronic mTOR activity in organs and tissues (immune cells, stem cells, endothelial cells, liver, adipose etc) suppresses autophagy and seems to be negative. That’s what we’re trying to avoid. We know that mTORC1 activity increases with age in all of those places, and it’s also driven by things like over-eating. But that’s more of a “baseline” or “chronic” mTORC1 activation, not the short-term, localised activation we see after exercise.
Basically what we’re wanting to know is: does exercising around Rapamycin blunt some of the Rapamycin benefits? Or, does exercising help us avoid some of the potential negatives of Rapamycin?
I did ask ChatGPT Pro (the $200/month version) and it gave a very complicated answer (with study references that I did briefly fact check and were correct) that basically with aging, we do see increased baseline mTOR activity in a subset of myocytes, and also satellite cells. In particularly, the neuromuscular junction (NMJ) (where your motor neurones tell the muscle to contract) seem particularly high in mTORC1 activity with age. And that is actually correlated with sarcopenia. That isn’t what I expected. Apparently animal studies show that Rapa is helping to preserve NMJ function and slow down muscle atrophy, rather than building size.
So IMO, coupling exercise around Rapamycin is a good thing because you have Rapa suppressing the “bad” mTOR activation around the body (immune, fat, liver etc), and the exercise still provides other benefits. Apparently you can’t “override” Rapamycin, so an older person where who is unlikely to make gains in muscle mass will get the maximum benefits in slowing atrophy while also still having plenty of other training stimulus; the glycogen depletion, the strain through tendons and joints, the mitochondrial stress, the cardiovascular benefits etc.
So personally I don’t see much logic in avoiding or reducing training about Rapamycin. IMO it should be the opposite. Any thoughts?